Safety and efficacy of 6 ‐month versus 12‐month dual antiplatelet therapy in patients after implantation of multiple biodegradable polymer‐coated sirolimus‐eluting coronary stents: Insight from the I‐LOVE‐IT 2 trial
ConclusionsIn patients treated with multiple BP‐SES, 6‐ and 12‐month DAPT had similar impacts on 12‐month clinical outcomes. Additionally, 12‐month DAPT might reduce TLF between 6 and 12 months at the cost of a slightly increased risk of all bleeding events. © 2017 Wiley Periodicals, Inc.
Source: Catheterization and Cardiovascular Interventions - Category: Cardiovascular & Thoracic Surgery Authors: Jing Qi, Yi Li, Jing Li, Quanmin Jing, Kai Xu, Chuanyu Gao, Likun Ma, Zhi Zhang, Bo Xu, Yaling Han Tags: Coronary Artery Disease Source Type: research
More News: Bleeding | Cardiac Catheterization | Cardiology | Cardiovascular | Cardiovascular & Thoracic Surgery | Heart | Heart Attack | Stroke | Study